TR199903154T2 - Meme kanserinin tedavisi ve te�hisi i�in bile�imler ve y�ntemler - Google Patents

Meme kanserinin tedavisi ve te�hisi i�in bile�imler ve y�ntemler

Info

Publication number
TR199903154T2
TR199903154T2 TR1999/03154T TR9903154T TR199903154T2 TR 199903154 T2 TR199903154 T2 TR 199903154T2 TR 1999/03154 T TR1999/03154 T TR 1999/03154T TR 9903154 T TR9903154 T TR 9903154T TR 199903154 T2 TR199903154 T2 TR 199903154T2
Authority
TR
Turkey
Prior art keywords
breast cancer
methods
compositions
diagnosis
treatment
Prior art date
Application number
TR1999/03154T
Other languages
English (en)
Turkish (tr)
Inventor
N. Frudakis Tony
M. Smith John
G.Reed Steven
Original Assignee
Corixa Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/991,789 external-priority patent/US6225054B1/en
Application filed by Corixa Corporation filed Critical Corixa Corporation
Publication of TR199903154T2 publication Critical patent/TR199903154T2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
TR1999/03154T 1997-04-09 1998-04-09 Meme kanserinin tedavisi ve te�hisi i�in bile�imler ve y�ntemler TR199903154T2 (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83876297A 1997-04-09 1997-04-09
US08/991,789 US6225054B1 (en) 1996-01-11 1997-12-11 Compositions and methods for the treatment and diagnosis of breast cancer

Publications (1)

Publication Number Publication Date
TR199903154T2 true TR199903154T2 (xx) 2000-08-21

Family

ID=27126060

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/03154T TR199903154T2 (xx) 1997-04-09 1998-04-09 Meme kanserinin tedavisi ve te�hisi i�in bile�imler ve y�ntemler

Country Status (12)

Country Link
EP (3) EP1127893A2 (OSRAM)
JP (1) JP4270523B2 (OSRAM)
KR (1) KR20010006220A (OSRAM)
AU (1) AU6956098A (OSRAM)
BR (1) BR9808509A (OSRAM)
CA (1) CA2286348A1 (OSRAM)
IL (1) IL132287A0 (OSRAM)
NO (1) NO994932L (OSRAM)
PL (1) PL336349A1 (OSRAM)
TR (1) TR199903154T2 (OSRAM)
WO (1) WO1998045328A2 (OSRAM)
ZA (1) ZA982968B (OSRAM)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030125536A1 (en) * 1996-01-11 2003-07-03 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US7241876B2 (en) 1996-01-11 2007-07-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6225054B1 (en) 1996-01-11 2001-05-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6861506B1 (en) 1996-01-11 2005-03-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6586570B1 (en) 1996-01-11 2003-07-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6828431B1 (en) 1999-04-09 2004-12-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6344550B1 (en) 1996-01-11 2002-02-05 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6656480B2 (en) 1996-01-11 2003-12-02 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US20020068285A1 (en) * 1996-01-11 2002-06-06 Frudakis Tony N. Compositions and methods for the therapy and diagnosis of breast cancer
US7598226B2 (en) 1998-12-28 2009-10-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6969518B2 (en) 1998-12-28 2005-11-29 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
NZ514646A (en) * 1999-04-09 2005-04-29 Corixa Corp Compositions and methods for the treatment and diagnosis of breast cancer
AU2004218695B2 (en) * 1999-04-09 2008-05-08 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
GB9916529D0 (en) * 1999-07-14 1999-09-15 Chiron Spa Antigenic peptides
AU1807401A (en) 1999-11-30 2001-06-12 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer
EP1666494A1 (en) * 1999-12-01 2006-06-07 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
JP2004505611A (ja) * 2000-04-03 2004-02-26 コリクサ　コーポレイション 乳癌の検出およびモニタリングのための方法、組成物、およびキット
DK1889630T3 (da) 2000-10-18 2012-03-05 Glaxosmithkline Biolog Sa Vacciner omfattende MAGE-antigen koblet til protein D-fragment
EP1425302A2 (en) * 2001-01-24 2004-06-09 Protein Design Labs Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
GB0109297D0 (en) 2001-04-12 2001-05-30 Glaxosmithkline Biolog Sa Vaccine
AU2003243151A1 (en) 2002-08-16 2004-03-03 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075109A (en) 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
US4897268A (en) 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
EP0444181B2 (en) * 1989-08-04 2010-11-24 Bayer Schering Pharma Aktiengesellschaft C-erbb-2 external domain: gp75
US5359681A (en) 1993-01-11 1994-10-25 University Of Washington Fiber optic sensor and methods and apparatus relating thereto
WO1995019369A1 (en) * 1994-01-14 1995-07-20 Vanderbilt University Method for detection and treatment of breast cancer
AU2690995A (en) * 1994-05-23 1995-12-18 Calypte Inc. Non-hiv antibodies as disease markers
US5668267A (en) * 1995-05-31 1997-09-16 Washington University Polynucleotides encoding mammaglobin, a mammary-specific breast cancer protein
JPH11510393A (ja) * 1995-08-09 1999-09-14 インスティチュート ナショナル ドゥ ラ セント エト ドゥ ラ リサーチェ メディカル 白血病マーカーとしておよび乳癌の予後において有用な単離された核酸分子
AU1575697A (en) * 1996-01-10 1997-08-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of cancer
EP1876241A3 (en) * 1996-01-11 2008-07-30 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer

Also Published As

Publication number Publication date
PL336349A1 (en) 2000-06-19
BR9808509A (pt) 2001-09-18
EP1964850A3 (en) 2012-06-20
ZA982968B (en) 1998-10-27
JP4270523B2 (ja) 2009-06-03
CA2286348A1 (en) 1998-10-15
WO1998045328A3 (en) 1999-04-22
AU6956098A (en) 1998-10-30
NO994932D0 (no) 1999-10-08
IL132287A0 (en) 2001-03-19
JP2001521384A (ja) 2001-11-06
KR20010006220A (ko) 2001-01-26
EP1127893A2 (en) 2001-08-29
WO1998045328A2 (en) 1998-10-15
EP1964850A2 (en) 2008-09-03
EP0975666A2 (en) 2000-02-02
NO994932L (no) 1999-12-07

Similar Documents

Publication Publication Date Title
NZ330887A (en) Monoclonals and polyclonals antibodies for the diagnosis of breast cancer
BR9808509A (pt) Composições e métodos para o tratamento e diagnóstico do câncer de mama
TR200103560T2 (tr) Göğüs kanserinin teşhis ve tedavisi için bileşimler ve bunların kullanımı
DE69713526D1 (de) Lösliche prodrugs von paclitaxel
DE60234793D1 (de) LIVP Stamm von Vaccinia-Virus zur Diagnose und Behandlung von Tumoren
ATE330967T1 (de) An her2 bindende peptidverbindungen
WO2002032292A3 (en) Methods for development and use of diagnostic and therapeutic agents
BR0112542A (pt) Composições e métodos papa a terapia e a diagnose de câncer ovariano
MXPA03006771A (es) Anticuerpos modificados y metodos de uso.
BR0110091A (pt) Composições e processos para terapia e diagnóstico de câncer de mama
ES2144391T3 (es) Derivados de alcoxi-4(1h)-piridona, sus procedimientos de preparacion y su utilizacion como medicamentos.
EP1706145A4 (en) AUTOANTIC BODY USED IN TUMOR IMAGING AND CANCER TREATMENT AS A CARRIER FOR PHARMACEUTICAL COMPOUNDS
WO2000052165A3 (en) Compositions and methods for breast cancer therapy and diagnosis
EP1427418A4 (en) PIPERAZINONE COMPOUNDS AS ANTITUMOROUS AND CANCER-COMBINING MEDICAMENTS AND TREATMENT PROCEDURES
NZ515388A (en) Polynucleotides and polypeptides used to stimulate leukocyte growth and to modulate angiogenesis and treat neurological conditions
CN104223115A (zh) 鱼鳞胶原蛋白多肽的新用途
WO2004104591A3 (en) Improvements to gamma delta t cell-mediated therapy
BR0009573A (pt) Composições e métodos para o tratamento e diagnose do câncer de mama
ATE514780T1 (de) Zusammensetzungen für die therapie und diagnose von brustkrebs und verwendung davon
DE60035192D1 (de) Tgf-alpha polypeptide, funktionelle fragmente und verfahren zu ihrer anwendung
BR0111024A (pt) Composições e métodos para a terapia e diagnóstico de câncer de mama
WO2002032954A3 (en) Phosphorylation modifications of apoptin
WO2004031354A3 (en) Human sarcoma-associated antigens
DE60139150D1 (de) Zusammensetzungen und verfahren zur therapie und diagnose von lungenkrebs
WO2005014804A3 (en) Ubiquitin-specific protease